About the Authors

Steve M. Taylor

steve.taylor@duke.edu

Affiliations Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, North Carolina, United States of America, Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, United States of America

Carla Cerami

Affiliation Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, United States of America

Rick M. Fairhurst

Affiliation Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

Competing Interests

CC has read the journal's policy and is on the Scientific Advisory Board and owns stock in Warren Pharmaceuticals, which is pursuing the clinical development of tissue-protective cytokines and peptides. SMT and RMF declare that they have no competing interests. This does not alter our adherence to all PLoS Pathogens policies on sharing data and materials.